Capricor Therapeutics is advancing deramiocel (CAP-1002) for DMD cardiomyopathy. Click here to find out why CAPR stock is a ...
A self-proclaimed 'MAGA Dentist' is facing backlash after a video of her joking about turning down pain-relieving gas for ...
With a potentially pivotal trial of its Duchenne muscular dystrophy (DMD) candidate CAP-1002 starting up, Capricor Therapeutics Inc. has tapped Nippon Shinyaku Co. Ltd. subsidiary NS Pharma Inc. to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback